Biocon launches its GLP-1 drug Liraglutide in the Netherlands, entering Europe with branded diabetes and obesity therapies, strengthening its GLP-1 and biologics portfolio.
GSK Nucala has moved a step closer to European approval after the EMA’s Committee for Medicinal Products for Human Use (CHMP) recommended the drug for adults with uncontrolled COPD marked by raised blood eosinophils.
Piramal Pharma Solutions NPS has reached a strong 55 for FY2025, signaling high customer loyalty and trust across its global operations. Announced today, the result highlights the company’s growing reputation as a reliable global CDMO and...
Indoco Remedies Limited has received a key regulatory clearance from the United States Food and Drug Administration (USFDA) for its Active Pharmaceutical Ingredients operations, strengthening its position in the global pharmaceutical supply chain...
.png "Lupin's LMS and PolyPeptide Form Alliance to Strengthen Peptide Supply")
Lupin Manufacturing Solutions (LMS), a subsidiary of Lupin Limited, announced a major strategic alliance today with PolyPeptide Group AG, marking a significant move in the expanding peptide market. The long-term partnership aims to build...
Piramal Pharma drew attention today as the US FDA wrapped up a general Good Manufacturing Practices inspection at the company’s Lexington, Kentucky site. The review, held from December 3 to December 10, 2025, ended with a Form 483 containing...
Pfizer’s HER2-targeted therapy TUKYSA delivered a strong boost in first-line maintenance treatment for HER2-positive metastatic breast cancer, marking a major advance in today’s data from the Phase 3 HER2CLIMB-05 trial.
Roche has announced fresh momentum in clinical diagnostics with CE Mark approval for its new mass spectrometry reagent pack, a move that strengthens its position in mass spectrometry testing. The approval expands what is now the broadest IVD...
Alembic Pharmaceuticals has received final FDA approval for its Loteprednol Etabonate and Tobramycin Ophthalmic Suspension, a generic version of the branded eye treatment Zylet. This achievement enhances the pipeline of U.S. generics at the...
Glenmark Pharmaceuticals announced today that its U.S. subsidiary will roll out Leucovorin Calcium for Injection USP, 350 mg/vial in December 2025. The drug is a single-dose vial and is both bioequivalent and therapeutically equivalent to...
.jpg)
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")